Notifying FDA of Fatalities Related to Blood Collection or Transfusion: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 20, 2021
April 18, 2024
00f8c605-19b4-4774-a558-04c89f70b1d1
Related Documents
Considerations for the Development of Dried Plasma Products Intended for Transfusion: Guidance for Industry
Guidance DocumentDecember 19, 2019Center for Biologics Evaluation and Research
Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Guidance for Industry
Guidance DocumentDecember 17, 2020Center for Biologics Evaluation and Research
Recommendations for Screening, Testing, and Management of Blood Donors and Blood and Blood Components Based on Screening Tests for Syphilis: Guidance for Industry
Guidance DocumentDecember 2, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.